PAUL F. GLENN 1930–2020
The Paul F.
Glenn Center for
Aging Research at
the recent passing of Paul F. Glenn
aging. Paul was
of humankind’s greatest challenges,
one that was
amenable to scientiﬁc study
and eventual intervention.
He realized that investment
in scientiﬁc research
aging would pay
of life for
people everywhere. Paul started
Glenn Foundation for Medical Research
early advocate for
the National Institute
Aging at NIH.
I knew Paul for about 15 years, and funding from the GFMR has been key to the research eﬀorts of the Guarente, Tsai, and Amon labs at MIT. The GFMR has ﬁgured in no small part in the ﬁeld of sirtuins/NAD+, one of the promising interventions to slow the eﬀects of aging and forestall diseases. Paul was a gentle soul, sharp of mind and soft of voice, but he radiated a steadfast purposefulness that drove the great success of the GFMR and aging research, generally. I will miss his kind smile and encouraging words greatly. He was truly one of a kind.
from the Director, Leonard P. Guarente
The Paul F. Glenn Center for Biology of Aging Research at MIT focuses on basic aspects of aging in a multi-tiered approach to provide novel ways to intervene in the aging process and potentially ameliorate health decline and diseases that occur at advancing ages. Projects include aging in adult stem cells, brain and muscle (Guarente lab), role of DNA damage and DNA repair in Alzheimer’s disease and brain aging (Tsai lab), and the role of chromosomal aneuploidy in aging (Amon lab). All told, this basic research will lead to new strategies to extend the period of robust health, which will provide considerable societal benefit.
The research work is carried out at 3 labs at MIT --
The Glenn Foundation for Medical Research generously funds this research work. Further information on what each lab is doing can be found on our Research page.